Related Experiment Video
Updated: Jul 22, 2026
07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
The Sentinel Node for Staging Breast Cancer: Current Review
Krag1
1Department of Surgery, University of Vermont College of Medicine, E-309, Given Building, Burlington, VT 05405, USA.
Breast Cancer (Tokyo, Japan)
|November 25, 2000
Summary
Sentinel node (SN) biopsy in breast cancer staging has evolved, offering high success rates over 90%. Further refinement is needed to optimize SN identification and reduce false negatives for accurate staging.
Area of Science:
- Oncology
- Surgical Oncology
- Pathology
Background:
- Lymph node removal in breast cancer has shifted from therapeutic to staging.
- Traditional methods of lymph node dissection have significant morbidity.
- Sentinel node (SN) biopsy represents a paradigm shift in breast cancer staging.
Purpose of the Study:
- To review the evolution and current status of sentinel node biopsy in breast cancer.
- To assess the efficacy and accuracy of SN resection.
- To identify areas for technical improvement in SN identification.
Main Methods:
- Review of available peer-reviewed literature on sentinel nodes in breast cancer.
- Analysis of reported success rates and accuracy of SN resection.
- Evaluation of technical challenges and false-negative rates.
Main Results:
- Sentinel node resection success rates exceed 90% with over 95% accuracy.
- The procedure has evolved from a therapeutic to a staging procedure.
- Technical challenges in SN identification and the need to reduce false-negative rates are highlighted.
Conclusions:
- Sentinel node biopsy is a highly accurate staging procedure for breast cancer.
- Ongoing research is crucial to optimize SN identification techniques.
- Minimizing false-negative rates is essential for patient management.
